Intrathecal daptomycin use in a challenging case of Enterococcus faecium ventriculitis
Open Access
- 8 April 2022
- journal article
- research article
- Published by Microbiology Society in Access Microbiology
- Vol. 4 (4) , 000230
Abstract
Treatment of ventriculitis caused by enterococci can be challenging, and antibiotic options are limited. We describe a case of device-related ventriculitis caused by vancomycin-resistant Enterococcus faecium , refractory to initial antibiotics. Our management approach included intrathecal daptomycin. There were no attributable adverse events, and the patient remained infection-free following ventriculo-peritoneal shunt insertion and cessation of antibiotics.Keywords
Funding Information
- Nil (no funding received)
This publication has 7 references indexed in Scilit:
- Stability of daptomycin reconstituted vials and infusion solutionsEuropean Journal of Hospital Pharmacy, 2016
- Compatibility of daptomycin with commercially available syringe filters.Hospital Pharmacy, 2015
- Compatibility of Daptomycin with Commercially Available Syringe FiltersHospital Pharmacy, 2015
- Central nervous system infections due to vancomycin-resistant enterococci: case series and review of the literatureInternational Journal of Infectious Diseases, 2014
- Intraventricular Daptomycin and Intravenous Linezolid for the Treatment of External Ventricular-Drain–Associated Ventriculitis Due to Vancomycin-Resistant Enterococcus faeciumAnnals of Pharmacotherapy, 2012
- Successful Use of Intrathecal Daptomycin to Treat Meningitis Due to Vancomycin-Resistant Enterococcus faeciumInfectious Diseases in Clinical Practice, 2012
- Treatment of external ventricular drain-associated ventriculitis caused by Enterococcus faecalis with intraventricular daptomycinJournal of Antimicrobial Chemotherapy, 2007